Professor, Obstetrics and Gynecology, USC School of Medicine

Obstetrics & Gynecology

Doctor Daniel J. Mishell, MD works in the field of Obstetrics & Gynecology. He received awards:"Fellow (FACOG)". Daniel Mishell is a published doctor and has 41 publications published. The lastest was: 'Development of a Cost-Effective Educational Tool to Promote Acceptance of the HPV Vaccination by Hispanic Mothers.'

Publications

---

• Development of a Cost-Effective Educational Tool to Promote Acceptance of the HPV Vaccination by Hispanic Mothers.
• Self-reported and verified compliance in a phase 3 clinical trial of a novel low-dose contraceptive patch and pill.
• New contraceptive patch wearability assessed by investigators and participants in a randomized phase 3 study.
• Safety and tolerability of a new low-dose contraceptive patch in obese and non-obese women.
• Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial.
• Effect of protease inhibitors on steady state pharmacokinetics of oral norethindrone contraception in HIV infected women.
• Ovarian activity in obese and nonobese women treated with three transdermal contraceptive patches delivering three different doses of ethinyl estradiol and levonorgest...
• Effects of progestin-only long-acting contraception on metabolic markers in obese women.
• Progestogens Used in Postmenopausal Hormone Therapy: Differences in Their Pharmacological Properties, Intracellular Actions, and Clinical Effects.
• Comparison of serum and cervical mucus hormone levels during hormone-free interval of 24/4 vs. 21/7 combined oral contraceptives.
• Comparison of cervical mucus of 24/4 vs. 21/7 combined oral contraceptives.
• Temporal changes in cervical mucus after insertion of the levonorgestrel-releasing intraUterine system.
• Randomized trial of estradiol Vaginal ring versus oral oxybutynin for the treatment of overactive bladder.
• Introduction to Population Council Symposium articles.
• Follicular development and ovulation in extremely obese women receiving depo-medroxyprogesterone acetate subcutaneously.
• Follicular development in a 7-day versus 4-day hormone-free interval with an oral contraceptive containing 20 mcg ethinyl estradiol and 1 mg norethindrone acetate.
• Breaking the cycle of Pain in interstitial cystitis/Painful bladder syndrome: toward standardization of early diagnosis and treatment: consensus panel recommendations.
• Evolving trends in the successful management of interstitial cystitis/Painful bladder syndrome.
• An oral contraceptive with 3 approved indications.
• YAZ and the novel progestin drospirenone.
• The postpartum visit: it's time for a change in order to optimally initiate contraception.
• IntraUterine contraception as an alternative to interval tubal sterilization.
• The effect of transdermal and Vaginal estrogen therapy on markers of postmenopausal estrogen status.
• Incisional endometriomas after Cesarean section: a case series.
• Combined hormonal contraceptive trials: variable data collection and bleeding assessment methodologies influence study outcomes and physician perception.
• Recommendations for standardization of data collection and analysis of bleeding in combined hormone contraceptive trials.
• Chronic pelvic pain in women: Focus on painful bladder syndrome/lnterstitial cystitis.
• Premenstrual disorders: epidemiology and disease burden.
• Increased prevalence of interstitial cystitis in women with detrusor overactivity refractory to anticholinergic therapy.
• Serum Nestorone and ethinyl estradiol levels, and ovulation inhibition in women using three different dosage combinations of a Nestorone progestogen-ethinyl estradiol ...
• Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone progestogen/ethinyl estradiol contraceptive Vaginal ring used on a b...
• Rationale for decreasing the number of days of the hormone-free interval with use of low-dose oral contraceptive formulations.
• Validation of Spanish version of Pelvic Pain and Urgency/Frequency (PUF) patient symptom scale.
• Contraceptive Vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial.
• IntraUterine contraception: benefits to patients.
• Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera.
• State of the art in hormonal contraception: an overview.
• Chronic pelvic pain in women: focus on the bladder.
• Vaginal rings delivering progesterone and estradiol may be a new method of hormone replacement therapy.
• Introduction: the role of hormone replacement therapy in prevention and treatment of cardiovascular disease in postmenopausal women.

Schools

---

• Stanford University School Of Medicine

• Harbor Genl Hospital

• Bellevue Hospital Center Cornell University

• Harbor Genl HospUcla

Procedures Preformed

---

• Gynecologic Cancer Screening

Conditions Treated

---

• Atrophic Vaginitis
• Chronic Pelvic Pain
• Endometriosis
• Hyperlipidemia
• View All

Doctors Specialties

---

• Obstetrics
• Gynecology

Accepted Insurances

---

Awards

---

• Fellow (FACOG)

Education

---

• Harbor - UCLA Medical Center

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Barry J. Brock, MD This Doctor is OpenDoctor Recommended.
	Dr. Scott E. Lentz, MD This Doctor is OpenDoctor Recommended.
	Dr. Alicia R. Crecelius, MD This Doctor is OpenDoctor Recommended.
	Dr. Guilda Zokaeem, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog